Clinical trialNCT04053673UnknownPhase 1Interventional

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

SponsorRibon Therapeutics, Inc.Enrollment130Solid Tumor, Adult

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Melissa L Johnson, MD
Tennessee Oncology
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain

Hospital Quironsalud Barcelona - Next Oncology
Barcelona, Spain
Fabricio Racca Bussano, MD
Recruiting
Vall D'Hebron
Barcelona, Spain
Josep Tabernero, MD
Recruiting
Hospital Quironsalud Madrid - Next Oncology
Madrid, Spain
Valentina Boni, MD
Recruiting
Hospital Clinic Universitario Biomedical Research Institute Incliva
Valencia, Spain
Andres Cervantes, MD
Recruiting

United States

University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Erin Schenk, MD
Recruiting
Scri-Denver/healthone
Denver, Colorado, United States
Gerald Falchook, MD
Recruiting
Yale Cancer Center, Yale University
New Haven, Connecticut, United States
Barbara Burtness, MD
Recruiting
Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, Florida, United States
Cesar Augusto Perez Batista, MD
Recruiting
Scri-Sarasota/florida Cancer Specialists
Sarasota, Florida, United States
Manish Patel, MD
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Geoffrey Shapiro, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Dejan Juric, MD
Recruiting
Washington University
St Louis, Missouri, United States
Saima Waqar, MD
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Yana Najjar, MD
Recruiting
Scri-Nashville/tennessee Oncology
Nashville, Tennessee, United States
Melissa L. Johnson, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Timothy A Yap, MD, PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Aug 2019
Primary completion: 30 Jun 2023
Completion: 31 Jul 2023
Last update posted: 28 Mar 2023
Registered enrollment: 130
Registry id: NCT04053673

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.